Chinese Companies Are Developing Advanced GLP-1 Drugs

Chinese Companies Are Developing Advanced GLP-1 Drugs

The research and development of new pharmaceuticals is increasingly an international affair, something that recent discussion about how tariffs might affect drug prices has made very clear. And even as GLP-1 drugs like Ozempic and Wegovy gain in popularity, scientists all over the world are looking for even more advanced drugs to address diabetes and weight loss.Some of that research has involved companies based in the United States, including E…

Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its auto-injector. The Chinese National Medical Products Administration (NMPA) approved Maxdutide, a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, developed by Innovent Biologics. It treats people with obesity through delivery with an YpsoMate 1.0 auto-injector variant. YpsoMate, a user-friendly de…